SPIMACO Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Public

  • Employees
  • 309

Employees

  • Stock Symbol
  • 2070

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $6.34
  • (As of Thursday Closing)

SPIMACO General Information

Description

Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; pharmaceutical production and wholesale and retail of medicines and related products; development and marketing of medicinal and pharmaceutical products; research and development in medical science activities; operating and maintaining the healthcare facilities and any investments in related industries. The segments of the company are Pharmaceutical Manufacturing, Trading and Distribution services, and Healthcare Services, out of which the company derives maximum revenue from the Pharmaceutical Manufacturing segment. Its geographical segments are Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • PO BOX 20001
  • Riyadh 11455
  • Saudi Arabia
+966 011
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Medical Supplies
Stock Exchange
SAU
Vertical(s)
Corporate Office
  • PO BOX 20001
  • Riyadh 11455
  • Saudi Arabia
+966 011

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SPIMACO Stock Performance

As of 12-Nov-2026, SPIMACO’s stock price is $6.34. Its current market cap is $756M with 119M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.34 $6.46 $6.07 - $8.82 $756M 119M 418K $0.48

SPIMACO Financials Summary

As of 30-Jun-2026, SPIMACO has a trailing 12-month revenue of $462M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,157,361 1,159,050 1,385,976 1,477,596
Revenue 461,733 454,665 447,237 440,201
EBITDA 109,115 103,286 65,118 40,147
Net Income 56,964 49,114 6,524 (13,489)
Total Assets 1,128,702 1,163,304 1,148,286 1,014,558
Total Debt 375,453 382,007 402,105 292,607
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SPIMACO Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SPIMACO‘s full profile, request access.

Request a free trial

SPIMACO Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances
Pharmaceuticals
Riyadh, Saudi Arabia
309 As of 2012

Ras Al Khaimah, United Arab Emirates
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SPIMACO Competitors (16)

One of SPIMACO’s 16 competitors is Gulf Pharmaceutical Industries, a Corporation company based in Ras Al Khaimah, United Arab Emirates.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gulf Pharmaceutical Industries Corporation Ras Al Khaimah, United Arab Emirates
Sun Pharmaceutical Industries Corporation Mumbai, India
Biocon Formerly PE-Backed Bengaluru, India
Cipla Corporation Mumbai, India
Hoechst Pakistan Corporate Backed or Acquired Karachi, Pakistan
You’re viewing 5 of 16 competitors. Get the full list »

SPIMACO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SPIMACO Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SPIMACO‘s full profile, request access.

Request a free trial

SPIMACO Investments & Acquisitions (7)

SPIMACO’s most recent deal was a Merger/Acquisition with Dammam Pharma for . The deal was made on 14-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dammam Pharma 14-Dec-2023 Merger/Acquisition Drug Discovery
Osmopharm 21-Nov-2023 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Meivo Pharmaceuticals 08-Dec-2015 Merger/Acquisition Pharmaceuticals
Mepho International Industry 29-Nov-2015 Merger/Acquisition Pharmaceuticals
EirGen Pharma 24-Mar-2012 Corporate Pharmaceuticals
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

SPIMACO ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

41.47 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view SPIMACO’s complete esg history, request access »

SPIMACO Exits (1)

SPIMACO’s most recent exit was on 24-Mar-2012 from EirGen Pharma. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
EirGen Pharma 24-Mar-2012 Completed
To view SPIMACO’s complete exits history, request access »

SPIMACO Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Osmopharm Bedano, Switzerland 1994

SPIMACO FAQs

  • When was SPIMACO founded?

    SPIMACO was founded in 1986.

  • Where is SPIMACO headquartered?

    SPIMACO is headquartered in Riyadh, Saudi Arabia.

  • What is the size of SPIMACO?

    SPIMACO has 309 total employees.

  • What industry is SPIMACO in?

    SPIMACO’s primary industry is Pharmaceuticals.

  • Is SPIMACO a private or public company?

    SPIMACO is a Public company.

  • What is SPIMACO’s stock symbol?

    The ticker symbol for SPIMACO is 2070.

  • What is the current stock price of SPIMACO?

    As of 12-Nov-2026 the stock price of SPIMACO is $6.34.

  • What is the current market cap of SPIMACO?

    The current market capitalization of SPIMACO is $756M.

  • What is SPIMACO’s current revenue?

    The trailing twelve month revenue for SPIMACO is $462M.

  • Who are SPIMACO’s competitors?

    Gulf Pharmaceutical Industries, Sun Pharmaceutical Industries, Biocon, Cipla, and Hoechst Pakistan are some of the 16 competitors of SPIMACO.

  • What is SPIMACO’s annual earnings per share (EPS)?

    SPIMACO’s EPS for 12 months was $0.48.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process